WallStSmart

iRhythm Technologies Inc (IRTC)vsStryker Corporation (SYK)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Stryker Corporation generates 3107% more annual revenue ($25.27B vs $787.85M). SYK leads profitability with a 13.2% profit margin vs -3.5%. SYK earns a higher WallStSmart Score of 57/100 (C).

IRTC

Avoid

30

out of 100

Grade: F

Growth: 7.3Profit: 2.0Value: 5.0Quality: 5.0
Piotroski: 4/9Altman Z: 0.28

SYK

Buy

57

out of 100

Grade: C

Growth: 6.0Profit: 6.5Value: 4.0Quality: 6.5
Piotroski: 3/9Altman Z: 2.18
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for IRTC.

SYKSignificantly Overvalued (-57.3%)

Margin of Safety

-57.3%

Fair Value

$224.01

Current Price

$352.25

$128.24 premium

UndervaluedFair: $224.01Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

IRTC1 strengths · Avg: 8.0/10
Revenue GrowthGrowth
25.7%8/10

Revenue surging 25.7% year-over-year

SYK1 strengths · Avg: 9.0/10
Market CapQuality
$118.55B9/10

Large-cap with strong market position

Areas to Watch

IRTC4 concerns · Avg: 2.5/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Price/BookValuation
24.9x2/10

Trading at 24.9x book value

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

Free Cash FlowQuality
$-33.08M2/10

Negative free cash flow — burning cash

SYK3 concerns · Avg: 3.7/10
P/E RatioValuation
36.4x4/10

Premium valuation, high expectations priced in

Revenue GrowthGrowth
2.6%4/10

2.6% revenue growth

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : IRTC

The strongest argument for IRTC centers on Revenue Growth. Revenue growth of 25.7% demonstrates continued momentum.

Bull Case : SYK

The strongest argument for SYK centers on Market Cap.

Bear Case : IRTC

The primary concerns for IRTC are EPS Growth, Price/Book, Return on Equity. Debt-to-equity of 4.52 is elevated, increasing financial risk.

Bear Case : SYK

The primary concerns for SYK are P/E Ratio, Revenue Growth, Piotroski F-Score.

Key Dynamics to Monitor

IRTC profiles as a growth stock while SYK is a value play — different risk/reward profiles.

IRTC carries more volatility with a beta of 1.27 — expect wider price swings.

IRTC is growing revenue faster at 25.7% — sustainability is the question.

SYK generates stronger free cash flow (415M), providing more financial flexibility.

Bottom Line

SYK scores higher overall (57/100 vs 30/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

iRhythm Technologies Inc

HEALTHCARE · MEDICAL DEVICES · USA

iRhythm Technologies, Inc., a digital healthcare company, offers ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. The company is headquartered in San Francisco, California.

Stryker Corporation

HEALTHCARE · MEDICAL DEVICES · USA

Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan. Stryker's products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment; neurosurgical, neurovascular and spinal devices; as well as other medical device products used in a variety of medical specialties.

Visit Website →

Want to dig deeper into these stocks?